Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trial.

The lancet. Gastroenterology & hepatology·2026
Same author

Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF Cohort.

JHEP reports : innovation in hepatology·2026
Same author

FRIES score: predicting conversion in robotic liver surgery.

BJS open·2026
Same author

Identifying Predictors of Failure-to-Rescue after Liver Transplantation: A Multicenter Analysis of 1341 Patients.

Clinical transplantation·2026
Same author

<sup>18</sup>F-FDG and <sup>18</sup>F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

ASO Visual Abstract: Enhanced Recovery After Liver Surgery: Does Compliance Impact Survival?

Annals of surgical oncology·2026

Related Experiment Video

Updated: Jul 7, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A

Rami Rhaiem1,2,3, Ammar Abdo4, Julien Calderaro2,5,6

  • 1Department of HPB and Oncological Digestive Surgery, Cabrol University Hospital, CHU de Reims, Reims, France.

Liver Cancer
|March 23, 2026
PubMed
Summary

Machine learning models, particularly random survival forest (RSF), significantly improve disease-free survival prediction after liver resection for hepatocellular carcinoma. RSF enhances patient selection for clinical trials evaluating adjuvant therapies.

Keywords:
Hepatocellular carcinomaLiver resectionRecurrenceSurvival

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jul 7, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Hepatobiliary Surgery
  • Oncology
  • Machine Learning in Medicine

Background:

  • Hepatocellular carcinoma (HCC) recurrence after liver resection (LR) remains high, necessitating accurate prognostication for patient selection in clinical trials.
  • Predicting disease-free survival (DFS) post-LR is critical for optimizing adjuvant treatment strategies.

Purpose of the Study:

  • To evaluate and compare the performance of machine learning (ML) models against traditional Cox regression for predicting DFS after LR in HCC patients.
  • To identify the most effective ML model for enhancing postoperative prognostication and clinical trial patient stratification.

Main Methods:

  • Analysis of 663 patients undergoing LR for HCC across three French centers.
  • Comparison of three ML models (Random Survival Forest, Gradient Boosting Survival, Fast Survival Support Vector Machine) with Cox regression.
  • Performance evaluation using C-index and time-dependent AUC, with external validation on a separate cohort.

Main Results:

  • Random Survival Forest (RSF) demonstrated superior discrimination and predictive accuracy in both training and external validation cohorts.
  • RSF significantly outperformed Cox regression (p < 0.05) for DFS prediction.
  • ML models, especially RSF, showed strong generalizability and outperformed Cox regression in external validation.

Conclusions:

  • RSF significantly improves DFS prediction accuracy compared to Cox regression for HCC patients undergoing LR.
  • ML-based survival models, particularly RSF, offer enhanced individualized prognostication.
  • These findings support the use of RSF for refining patient selection in clinical trials for adjuvant therapies post-LR for HCC.